Human antibody pembrolizumab offers new hope to patients
Encouraging results from early human trial
Viewing it as multiple diseases that share a location
Correcting an irrational imbalance in oncotherapeutic care
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Endoscopic submucosal dissection is gaining popularity
Upfront treatment in advanced disease is a new standard of care
An alternative to external beam whole-breast irradiation
SBRT and PBT could shape the future of treatment
Clinics designed for high-risk patients, young women
A hematologist wrestles with how to help leukemia patients make the right treatment choices
Advertisement
Advertisement